Regulatory, legal and policy aspects

Workpackage #8

Regulatory, legal and policy aspects

iCARE4CVD’s vision to pave the way to better care for individuals with
CVD could not be realised without careful insight into the regulatory, legal,
reimbursement, and policy landscape relevant to CVD. By defining a
roadmap, framework, and a strategy for biomarker and medical AI
developments that is safe, ethical, and successful, WP8 will aim to
facilitate a successful adaption and implementation of iCARE4CVD’s
medical tools.

Meet our team

TNO

Willem van den Brink, PhD

Senior scientist – Digital Biomarkers Lead

Scientific Institute for Health Economics and Health Systems Research

Ines Weinhold

Managing Director at WIG2
Kirsten Budig

Novo Nordisk

Kirsten Budig

Senior Public Affairs Manager

Scientific Institute for Health Economics and Health Systems Research

Franziska Sende

Research associate

TNO

Gabriela Bodea, MA

Dutch Organisation for Applied Research
Get updated

Our related news

31 March, 2025

Neem deel aan de INSPIRE e-Health-enquête (Nederlandse versie)

Deel uw ervaringen met digitale hulpmiddelen, mobiele apps en draagbare apparaten en..

31 March, 2025

Nehmen Sie an der INSPIRE e-Health-Umfrage (deutsche Version) teil

Teilen Sie Ihre Erfahrungen mit digitalen Lösungen, wie Gesundheits-Apps und Wearables, und..

27 March, 2025

Can digital tools improve treatment adherence in CVD?

A closer look into how iCARE4CVD is addressing this challenge…

Subscribe to our newsletter

Subscribe to our newsletter to stay up to date with all the most recent information about iCARE4CVD.